Roivant Sciences’ $400 Million At-The-Market Offering

Davis Polk advised Roivant Sciences Ltd. in the offering.Roivant Sciences Ltd. announced its at-the-market offering program under which Roivant may issue and sell its common shares through…

This content is for members only.
Login to Read More Join Now
Laura Testa

Author: Laura Testa

This content is for members only.
Login to Read More Join Now